{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T04:24:49Z","timestamp":1741839889347,"version":"3.38.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Science and Technology Council, Taiwan.","award":["NSTC 112-2813-C-037-031-B"],"award-info":[{"award-number":["NSTC 112-2813-C-037-031-B"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-024-04320-1","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T18:41:27Z","timestamp":1733510487000},"page":"1175-1187","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Overexpression of BMAL-1 is related to progression of urothelial carcinoma in arsenic exposure area"],"prefix":"10.1007","volume":"57","author":[{"given":"Yu-Jui","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Jyuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Shuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chee-Yin","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"issue":"5","key":"4320_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1177\/000331970205300505","volume":"53","author":"CH Tseng","year":"2002","unstructured":"Tseng CH (2002) An overview on peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Angiology 53(5):529\u2013537. https:\/\/doi.org\/10.1177\/000331970205300505","journal-title":"Angiology"},{"issue":"6","key":"4320_CR2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1177\/000331978904000606","volume":"40","author":"WP Tseng","year":"1989","unstructured":"Tseng WP (1989) Blackfoot disease in Taiwan: a 30-year follow-up study. Angiology 40(6):547\u2013558. https:\/\/doi.org\/10.1177\/000331978904000606","journal-title":"Angiology"},{"issue":"1","key":"4320_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1579\/0044-7447(2007)36[82:bditil]2.0.co;2","volume":"36","author":"CH Tseng","year":"2007","unstructured":"Tseng CH, Chong CK, Tseng CP, Centeno JA (2007) Blackfoot disease in Taiwan: its link with inorganic arsenic exposure from drinking water. Ambio 36(1):82\u201384. https:\/\/doi.org\/10.1579\/0044-7447(2007)36[82:bditil]2.0.co;2","journal-title":"Ambio"},{"issue":"5","key":"4320_CR4","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1161\/01.atv.8.5.452","volume":"8","author":"CJ Chen","year":"1988","unstructured":"Chen CJ, Wu MM, Lee SS, Wang JD, Cheng SH, Wu HY (1988) Atherogenicity and carcinogenicity of high-arsenic artesian well water multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis 8(5):452\u2013460. https:\/\/doi.org\/10.1161\/01.atv.8.5.452","journal-title":"Arteriosclerosis"},{"issue":"5","key":"4320_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/aje\/153.5.411","volume":"153","author":"HY Chiou","year":"2001","unstructured":"Chiou HY, Chiou ST, Hsu YH, Chou YL, Tseng CH, Wei ML, Chen CJ (2001) Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 153(5):411\u2013418. https:\/\/doi.org\/10.1093\/aje\/153.5.411","journal-title":"Am J Epidemiol"},{"issue":"1","key":"4320_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12885-021-07799-4","volume":"21","author":"CW Chang","year":"2021","unstructured":"Chang CW, Ou CH, Yu CC, Lo CW, Tsai CY, Cheng PY, Chen YT, Huang HC, Wu CC, Li CC, Lee HY (2021) Comparative analysis of patients with upper urinary tract urothelial carcinoma in black-foot disease endemic and non-endemic area. BMC Cancer 21(1):80. https:\/\/doi.org\/10.1186\/s12885-021-07799-4","journal-title":"BMC Cancer"},{"issue":"2","key":"4320_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1158\/1055-9965.Epi-20-1090","volume":"30","author":"CH Chen","year":"2021","unstructured":"Chen CH, Grollman AP, Huang CY, Shun CT, Sidorenko VS, Hashimoto K, Moriya M, Turesky RJ, Yun BH, Tsai K, Wu S, Chuang PY, Tang CH, Yang WH, Tzai TS, Tsai YS, Dickman KG, Pu YS (2021) Additive Effects of arsenic and aristolochic acid in chemical carcinogenesis of upper urinary tract urothelium. Cancer Epidemiol Biomarkers Prev 30(2):317\u2013325. https:\/\/doi.org\/10.1158\/1055-9965.Epi-20-1090","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"4320_CR8","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jfma.2013.05.012","volume":"112","author":"CC Wu","year":"2013","unstructured":"Wu CC, Chen MC, Huang YK, Huang CY, Lai LA, Chung CJ, Shiue HS, Pu YS, Lin YC, Han BC, Wang YH, Hsueh YM (2013) Environmental tobacco smoke and arsenic methylation capacity are associated with urothelial carcinoma. J Formos Med Assoc 112(9):554\u2013560. https:\/\/doi.org\/10.1016\/j.jfma.2013.05.012","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"4320_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.taap.2009.08.008","volume":"241","author":"YH Wang","year":"2009","unstructured":"Wang YH, Yeh SD, Shen KH, Shen CH, Juang GD, Hsu LI, Chiou HY, Chen CJ (2009) A significantly joint effect between arsenic and occupational exposures and risk genotypes\/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma. Toxicol Appl Pharmacol 241(1):111\u2013118. https:\/\/doi.org\/10.1016\/j.taap.2009.08.008","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"4320_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.taap.2007.10.024","volume":"227","author":"LI Hsu","year":"2008","unstructured":"Hsu LI, Chiu AW, Pu YS, Wang YH, Huan SK, Hsiao CH, Hsieh FI, Chen CJ (2008) Comparative genomic hybridization study of arsenic-exposed and non-arsenic-exposed urinary transitional cell carcinoma. Toxicol Appl Pharmacol 227(2):229\u2013238. https:\/\/doi.org\/10.1016\/j.taap.2007.10.024","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"4320_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.taap.2008.06.011","volume":"232","author":"CJ Chung","year":"2008","unstructured":"Chung CJ, Huang CJ, Pu YS, Su CT, Huang YK, Chen YT, Hsueh YM (2008) Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma. Toxicol Appl Pharmacol 232(2):203\u2013209. https:\/\/doi.org\/10.1016\/j.taap.2008.06.011","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"4320_CR12","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/j.1365-2559.2007.02871.x","volume":"51","author":"WT Chen","year":"2007","unstructured":"Chen WT, Hung WC, Kang WY, Huang YC, Chai CY (2007) Urothelial carcinomas arising in arsenic-contaminated areas are associated with hypermethylation of the gene promoter of the death-associated protein kinase. Histopathology 51(6):785\u2013792. https:\/\/doi.org\/10.1111\/j.1365-2559.2007.02871.x","journal-title":"Histopathology"},{"issue":"8","key":"4320_CR13","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s00204-015-1590-x","volume":"90","author":"CY Huang","year":"2016","unstructured":"Huang CY, Pu YS, Shiue HS, Chen WJ, Lin YC, Hsueh YM (2016) Polymorphisms of human 8-oxoguanine DNA glycosylase 1 and 8-hydroxydeoxyguanosine increase susceptibility to arsenic methylation capacity-related urothelial carcinoma. Arch Toxicol 90(8):1917\u20131927. https:\/\/doi.org\/10.1007\/s00204-015-1590-x","journal-title":"Arch Toxicol"},{"key":"4320_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.154173","volume":"240","author":"SJ Chang","year":"2022","unstructured":"Chang SJ, Bin PJ, Luo CW, Chai CY (2022) CHD4 plays a critical role in arsenite-induced oxidative damage in human urothelial carcinoma. Pathol Res Pract 240:154173. https:\/\/doi.org\/10.1016\/j.prp.2022.154173","journal-title":"Pathol Res Pract"},{"issue":"1","key":"4320_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.taap.2013.05.019","volume":"272","author":"CC Wu","year":"2013","unstructured":"Wu CC, Huang YK, Chung CJ, Huang CY, Pu YS, Shiue HS, Lai LA, Lin YC, Su CT, Hsueh YM (2013) Polymorphism of inflammatory genes and arsenic methylation capacity are associated with urothelial carcinoma. Toxicol Appl Pharmacol 272(1):30\u201336. https:\/\/doi.org\/10.1016\/j.taap.2013.05.019","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"4320_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/ijc.31290","volume":"143","author":"A Ooki","year":"2018","unstructured":"Ooki A, Begum A, Marchionni L, VandenBussche CJ, Mao S, Kates M, Hoque MO (2018) Arsenic promotes the COX2\/PGE2-SOX2 axis to increase the malignant stemness properties of urothelial cells. Int J Cancer 143(1):113\u2013126. https:\/\/doi.org\/10.1002\/ijc.31290","journal-title":"Int J Cancer"},{"issue":"2","key":"4320_CR17","doi-asserted-by":"publisher","first-page":"R294","DOI":"10.1152\/ajpregu.00522.2016","volume":"314","author":"AG Kirkley","year":"2018","unstructured":"Kirkley AG, Carmean CM, Ruiz D, Ye H, Regnier SM, Poudel A, Hara M, Kamau W, Johnson DN, Roberts AA, Parsons PJ, Seino S, Sargis RM (2018) Arsenic exposure induces glucose intolerance and alters global energy metabolism. Am J Physiol Regul Integr Comp Physiol 314(2):R294-r303. https:\/\/doi.org\/10.1152\/ajpregu.00522.2016","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"4320_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2020.110162","author":"N Zhu","year":"2020","unstructured":"Zhu N, Li Y, Jiao J, Yun Y, Ku T, Liang D, Sang N (2020) Investigating photo-driven arsenics\u2019 behavior and their glucose metabolite toxicity by the typical metallic oxides in ambient PM(2.5). Ecotoxicol Environ Saf. https:\/\/doi.org\/10.1016\/j.ecoenv.2020.110162","journal-title":"Ecotoxicol Environ Saf"},{"issue":"1","key":"4320_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1021\/acschemneuro.8b00278","volume":"10","author":"SA Ni\u00f1o","year":"2019","unstructured":"Ni\u00f1o SA, Morales-Mart\u00ednez A, Chi-Ahumada E, Carrizales L, Salgado-Delgado R, P\u00e9rez-Severiano F, D\u00edaz-Cintra S, Jim\u00e9nez-Capdeville ME, Zaraz\u00faa S (2019) Arsenic exposure contributes to the bioenergetic damage in an Alzheimer\u2019s disease model. ACS Chem Neurosci 10(1):323\u2013336. https:\/\/doi.org\/10.1021\/acschemneuro.8b00278","journal-title":"ACS Chem Neurosci"},{"key":"4320_CR20","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1186\/s12885-016-2580-y","volume":"16","author":"J Litlekalsoy","year":"2016","unstructured":"Litlekalsoy J, Rostad K, Kalland KH, Hostmark JG, Laerum OD (2016) Expression of circadian clock genes and proteins in urothelial cancer is related to cancer-associated genes. BMC Cancer 16:549. https:\/\/doi.org\/10.1186\/s12885-016-2580-y","journal-title":"BMC Cancer"},{"issue":"2","key":"4320_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10534-010-9292-6","volume":"23","author":"V Jim\u00e9nez-Ortega","year":"2010","unstructured":"Jim\u00e9nez-Ortega V, Cardinali DP, Fern\u00e1ndez-Mateos MP, R\u00edos-Lugo MJ, Scacchi PA, Esquifino AI (2010) Effect of cadmium on 24-hour pattern in expression of redox enzyme and clock genes in rat medial basal hypothalamus. Biometals 23(2):327\u2013337. https:\/\/doi.org\/10.1007\/s10534-010-9292-6","journal-title":"Biometals"},{"issue":"2","key":"4320_CR22","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1158\/0008-5472.Can-16-1322","volume":"77","author":"Q Tang","year":"2017","unstructured":"Tang Q, Cheng B, Xie M, Chen Y, Zhao J, Zhou X, Chen L (2017) Circadian clock gene bmal1 inhibits tumorigenesis and increases paclitaxel sensitivity in tongue squamous cell carcinoma. Cancer Res 77(2):532\u2013544. https:\/\/doi.org\/10.1158\/0008-5472.Can-16-1322","journal-title":"Cancer Res"},{"issue":"6","key":"4320_CR23","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.3892\/or.2013.2381","volume":"29","author":"CH Jung","year":"2013","unstructured":"Jung CH, Kim EM, Park JK, Hwang SG, Moon SK, Kim WJ, Um HD (2013) Bmal1 suppresses cancer cell invasion by blocking the phosphoinositide 3-kinase-Akt-MMP-2 signaling pathway. Oncol Rep 29(6):2109\u20132113. https:\/\/doi.org\/10.3892\/or.2013.2381","journal-title":"Oncol Rep"},{"issue":"1","key":"4320_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s13277-011-0258-2","volume":"33","author":"CM Hsu","year":"2012","unstructured":"Hsu CM, Lin SF, Lu CT, Lin PM, Yang MY (2012) Altered expression of circadian clock genes in head and neck squamous cell carcinoma. Tumour Biol 33(1):149\u2013155. https:\/\/doi.org\/10.1007\/s13277-011-0258-2","journal-title":"Tumour Biol"},{"key":"4320_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fonc.2018.00185","volume":"8","author":"LVM de Assis","year":"2018","unstructured":"de Assis LVM, Kinker GS, Moraes MN, Markus RP, Fernandes PA, Castrucci AML (2018) Expression of the circadian clock gene BMAL1 positively correlates with antitumor immunity and patient survival in metastatic melanoma. Front Oncol 8:185. https:\/\/doi.org\/10.3389\/fonc.2018.00185","journal-title":"Front Oncol"},{"key":"4320_CR26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12935-019-0902-2","volume":"19","author":"J Wang","year":"2019","unstructured":"Wang J, Li S, Li X, Li B, Li Y, Xia K, Yang Y, Aman S, Wang M, Wu H (2019) Circadian protein BMAL1 promotes breast cancer cell invasion and metastasis by up-regulating matrix metalloproteinase9 expression. Cancer Cell Int 19:182. https:\/\/doi.org\/10.1186\/s12935-019-0902-2","journal-title":"Cancer Cell Int"},{"issue":"4","key":"4320_CR27","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1002\/cam4.5129","volume":"12","author":"L Shan","year":"2023","unstructured":"Shan L, Zheng W, Bai B, Hu J, Lv Y, Chen K, Wang X, Pan Y, Huang X, Zhu H, Dai S (2023) BMAL1 promotes colorectal cancer cell migration and invasion through ERK- and JNK-dependent c-Myc expression. Cancer Med 12(4):4472\u20134485. https:\/\/doi.org\/10.1002\/cam4.5129","journal-title":"Cancer Med"},{"issue":"9","key":"4320_CR28","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101398R","volume":"36","author":"B Fekry","year":"2022","unstructured":"Fekry B, Ribas-Latre A, Drunen RV, Santos RB, Shivshankar S, Dai Y, Zhao Z, Yoo SH, Chen Z, Sun K, Sladek FM, Younes M, Eckel-Mahan K (2022) Hepatic circadian and differentiation factors control liver susceptibility for fatty liver disease and tumorigenesis. Faseb j 36(9):e22482. https:\/\/doi.org\/10.1096\/fj.202101398R","journal-title":"Faseb j"},{"issue":"5","key":"4320_CR29","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.3892\/ol.2017.6876","volume":"14","author":"T Momma","year":"2017","unstructured":"Momma T, Okayama H, Saitou M, Sugeno H, Yoshimoto N, Takebayashi Y, Ohki S, Takenoshita S (2017) Expression of circadian clock genes in human colorectal adenoma and carcinoma. Oncol Lett 14(5):5319\u20135325. https:\/\/doi.org\/10.3892\/ol.2017.6876","journal-title":"Oncol Lett"},{"issue":"1","key":"4320_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12885-017-3253-1","volume":"17","author":"YT Kao","year":"2017","unstructured":"Kao YT, Wu CH, Wu SY, Lan SH, Liu HS, Tseng YS (2017) Arsenic treatment increase Aurora-A overexpression through E2F1 activation in bladder cells. BMC Cancer 17(1):277. https:\/\/doi.org\/10.1186\/s12885-017-3253-1","journal-title":"BMC Cancer"},{"issue":"1","key":"4320_CR31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.18388\/abp.2020_5452","volume":"68","author":"X Han","year":"2021","unstructured":"Han X, Liu H, Tang X, Zhao Y (2021) MiRNA-621 exerts tumor suppressor function in gastric adenocarcinoma by targeting AURKA\/GSK-3\u03b2 pathway. Acta Biochim Pol 68(1):91\u201398. https:\/\/doi.org\/10.18388\/abp.2020_5452","journal-title":"Acta Biochim Pol"},{"issue":"1","key":"4320_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008561","volume":"5","author":"S Sahar","year":"2010","unstructured":"Sahar S, Zocchi L, Kinoshita C, Borrelli E, Sassone-Corsi P (2010) Regulation of BMAL1 protein stability and circadian function by GSK3beta-mediated phosphorylation. PLoS ONE 5(1):e8561. https:\/\/doi.org\/10.1371\/journal.pone.0008561","journal-title":"PLoS ONE"},{"issue":"8","key":"4320_CR33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10653-024-02069-1","volume":"46","author":"YL Chung","year":"2024","unstructured":"Chung YL, Lin MH, Liaw YP, Guo HR (2024) Dose-response relationship between arsenic in drinking water and mortality of urinary cancers in Taiwan. Environ Geochem Health 46(8):299. https:\/\/doi.org\/10.1007\/s10653-024-02069-1","journal-title":"Environ Geochem Health"},{"key":"4320_CR34","doi-asserted-by":"publisher","first-page":"1610230","DOI":"10.3389\/pore.2022.1610230","volume":"28","author":"SJ Chang","year":"2022","unstructured":"Chang SJ, Chao CT, Kwan AL, Chai CY (2022) The diagnostic significance of CXCL13 in M2 tumor immune microenvironment of human astrocytoma. Pathol Oncol Res 28:1610230. https:\/\/doi.org\/10.3389\/pore.2022.1610230","journal-title":"Pathol Oncol Res"},{"issue":"12","key":"4320_CR35","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.urolonc.2019.09.009","volume":"37","author":"EF Burgess","year":"2019","unstructured":"Burgess EF, Livasy C, Trufan S, Hartman A, Guerreri R, Naso C, Clark PE, Grigg C, Symanowski J, Raghavan D (2019) High aurora kinase expression identifies patients with muscle-invasive bladder cancer who have poor survival after neoadjuvant chemotherapy. Urol Oncol 37(12):900\u2013906. https:\/\/doi.org\/10.1016\/j.urolonc.2019.09.009","journal-title":"Urol Oncol"},{"key":"4320_CR36","doi-asserted-by":"publisher","first-page":"3342666","DOI":"10.1155\/2022\/3342666","volume":"2022","author":"Y Guo","year":"2022","unstructured":"Guo Y, Zhang YB, Li Y, Su WH, He S, Pan SP, Xu K, Kou WH (2022) Three prognostic biomarkers correlate with immune checkpoint blockade response in bladder urothelial carcinoma. Int J Genomics 2022:3342666. https:\/\/doi.org\/10.1155\/2022\/3342666","journal-title":"Int J Genomics"},{"issue":"Suppl 7","key":"4320_CR37","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12918-018-0634-2","volume":"12","author":"M Guo","year":"2018","unstructured":"Guo M, Lu S, Huang H, Wang Y, Yang MQ, Yang Y, Fan Z, Jiang B, Deng Y (2018) Increased AURKA promotes cell proliferation and predicts poor prognosis in bladder cancer. BMC Syst Biol 12(Suppl 7):118. https:\/\/doi.org\/10.1186\/s12918-018-0634-2","journal-title":"BMC Syst Biol"},{"issue":"1","key":"4320_CR38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.canlet.2015.09.018","volume":"370","author":"HY Hsieh","year":"2016","unstructured":"Hsieh HY, Shen CH, Lin RI, Feng YM, Huang SY, Wang YH, Wu SF, Hsu CD, Chan MW (2016) Cyproheptadine exhibits antitumor activity in urothelial carcinoma cells by targeting GSK3\u03b2 to suppress mTOR and \u03b2-catenin signaling pathways. Cancer Lett 370(1):56\u201365. https:\/\/doi.org\/10.1016\/j.canlet.2015.09.018","journal-title":"Cancer Lett"},{"issue":"1","key":"4320_CR39","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3727\/096504017x14902261600566","volume":"26","author":"R Wang","year":"2018","unstructured":"Wang R, Wu Y, Huang W, Chen W (2018) MicroRNA-940 targets INPP4A or GSK3\u03b2 and activates the Wnt\/\u03b2-catenin pathway to regulate the malignant behavior of bladder cancer cells. Oncol Res 26(1):145\u2013155. https:\/\/doi.org\/10.3727\/096504017x14902261600566","journal-title":"Oncol Res"},{"key":"4320_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.canlet.2021.09.036","volume":"523","author":"X Li","year":"2021","unstructured":"Li X, Wei Z, Yu H, Xu Y, He W, Zhou X, Gou X (2021) Secretory autophagy-induced bladder tumour-derived extracellular vesicle secretion promotes angiogenesis by activating the TPX2-mediated phosphorylation of the AURKA-PI3K-AKT axis. Cancer Lett 523:10\u201328. https:\/\/doi.org\/10.1016\/j.canlet.2021.09.036","journal-title":"Cancer Lett"},{"key":"4320_CR41","doi-asserted-by":"publisher","first-page":"963689722107792","DOI":"10.1177\/09636897221077921","volume":"31","author":"S Xiong","year":"2022","unstructured":"Xiong S, Huang W, Liu X, Chen Q, Ding Y, Huang H, Zhang R, Guo J (2022) Celecoxib synergistically enhances MLN4924-induced cytotoxicity and EMT inhibition Via AKT and ERK pathways in human urothelial carcinoma. Cell Transplant 31:9636897221077920. https:\/\/doi.org\/10.1177\/09636897221077921","journal-title":"Cell Transplant"},{"issue":"2","key":"4320_CR42","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.cbi.2009.06.020","volume":"181","author":"YC Huang","year":"2009","unstructured":"Huang YC, Hung WC, Chen WT, Yu HS, Chai CY (2009) Sodium arsenite-induced DAPK promoter hypermethylation and autophagy via ERK1\/2 phosphorylation in human uroepithelial cells. Chem Biol Interact 181(2):254\u2013262. https:\/\/doi.org\/10.1016\/j.cbi.2009.06.020","journal-title":"Chem Biol Interact"},{"issue":"1\u20132","key":"4320_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.toxlet.2010.10.015","volume":"200","author":"YC Huang","year":"2011","unstructured":"Huang YC, Hung WC, Chen WT, Jiang WH, Yu HS, Chai CY (2011) Effects of MEK and DNMT inhibitors on arsenic-treated human uroepithelial cells in relation to Cyclin-D1 and p16. Toxicol Lett 200(1\u20132):59\u201366. https:\/\/doi.org\/10.1016\/j.toxlet.2010.10.015","journal-title":"Toxicol Lett"},{"key":"4320_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.915139","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang W, Xiong Y, Tao R, Panayi AC, Mi B, Liu G (2022) Emerging insight into the role of circadian clock gene BMAL1 in cellular senescence. Front Endocrinol (Lausanne) 13:915139. https:\/\/doi.org\/10.3389\/fendo.2022.915139","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"4320_CR45","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1158\/1078-0432.Ccr-18-2039","volume":"25","author":"F Audenet","year":"2019","unstructured":"Audenet F, Isharwal S, Cha EK, Donoghue MTA, Drill EN, Ostrovnaya I, Pietzak EJ, Sfakianos JP, Bagrodia A, Murugan P, Dalbagni G, Donahue TF, Rosenberg JE, Bajorin DF, Arcila ME, Hechtman JF, Berger MF, Taylor BS, Al-Ahmadie H, Iyer G, Bochner BH, Coleman JA, Solit DB (2019) Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma. Clin Cancer Res 25(3):967\u2013976. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-2039","journal-title":"Clin Cancer Res"},{"issue":"2","key":"4320_CR46","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.euo.2020.12.007","volume":"4","author":"JP Sfakianos","year":"2021","unstructured":"Sfakianos JP, Gul Z, Shariat SF, Matin SF, Daneshmand S, Plimack E, Lerner S, Roupret M, Pal S (2021) Genetic differences between bladder and upper urinary tract carcinoma: implications for therapy. Eur Urol Oncol 4(2):170\u2013179. https:\/\/doi.org\/10.1016\/j.euo.2020.12.007","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"4320_CR47","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41585-022-00578-1","volume":"19","author":"JY Teoh","year":"2022","unstructured":"Teoh JY, Kamat AM, Black PC, Grivas P, Shariat SF, Babjuk M (2022) Recurrence mechanisms of non-muscle-invasive bladder cancer - a clinical perspective. Nat Rev Urol 19(5):280\u2013294. https:\/\/doi.org\/10.1038\/s41585-022-00578-1","journal-title":"Nat Rev Urol"},{"issue":"3","key":"4320_CR48","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00428-021-03145-y","volume":"479","author":"K Haghayeghi","year":"2021","unstructured":"Haghayeghi K, Lu S, Matoso A, Schiff SF, Mueller-Leonhard C, Amin A (2021) Association of current molecular subtypes in urothelial carcinoma with patterns of muscularis propria invasion. Virchows Arch 479(3):515\u2013521. https:\/\/doi.org\/10.1007\/s00428-021-03145-y","journal-title":"Virchows Arch"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-04320-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-024-04320-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-04320-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T01:28:23Z","timestamp":1741829303000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-024-04320-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["4320"],"URL":"https:\/\/doi.org\/10.1007\/s11255-024-04320-1","relation":{},"ISSN":["1573-2584"],"issn-type":[{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2024,12,6]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study protocol was reviewed and approved by the Institutional Review Board at Kaohsiung Medical University Hospital, Taiwan. The approval number is KMUHIRB-E(I)-20210053.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}